EDGAR Filing Documents for 0001193125-15-308107

Form SC 13D - General Statement of Acquisition of Beneficial Ownership:

SEC Accession No. 0001193125-15-308107

Filing Date

2015-08-31

Accepted

2015-08-31 15:30:59

Documents

Group Members

ESSEX WOODLANDS HEALTH VENTURES FUND VIII, L.P.ESSEX WOODLANDS HEALTH VENTURES VIII, L.P.GUIDO NEELSIMMANUEL THANGARAJJAMES CURRIEJEFF HIMAWAN, PH.D.MARTIN SUTTERPETRI VAINIORON EASTMANSTEVE WIGGINS

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	d57121dsc13d.htm	SC 13D	190047
2	EX-99.A	d57121dex99a.htm	EX-99.A	14608
	Complete submission text file	0001193125-15-308107.txt		206548

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655

CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82442 | Film No.: 151084763
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380

Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 2813641555

Essex Woodlands Health Ventures VIII, L.L.C. (Filed by) CIK: 0001632027 (see all company filings)

IRS No.: 261923296
Type: SC 13D